Allos Therapeutics (ALTH) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	93.4M
Short-term investments
Restricted cash	238K
Accounts receivable	9.69M
Inventory	856K
Prepaid expenses and other assets	2.27M
Total current assets	106.5M
Property and equipment, net	1.26M
Long-term investments
Intangible asset, net	4.66M
Other assets
Total assets	112.42M
Trade accounts payable	3.28M
Deferred revenue	2.78M
Accrued liabilities	13.95M
Total current liabilities	20.01M
Long-term deferred revenue
Commitments and contingencies (Note 11)	0
Stockholders' equity:
Common stock, $0.001 par value; 200,000,000 shares authorized; 105,673,986 and 105,493,546 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	107K
Additional paid-in capital	563.25M
Accumulated deficit	-492.47M
Total stockholders' equity	70.88M
Total liabilities and stockholders' equity	112.42M
Stockholders' equity:
Preferred stock, $0.001 par value; no shares issued or outstanding	0
Stockholders' equity:
Preferred stock, $0.001 par value; no shares issued or outstanding	0

Entities mentioned with ALTH

View All Entities